GBIO
Income statement / Annual
Last year (2023), Generation Bio Co.'s total revenue was $5.90 M,
and the percentage change from the previous year is not available.
In 2023, Generation Bio Co.'s net income was -$126.61 M.
See Generation Bio Co.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
Operating Revenue |
$5.90 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$36,000.00
|
Cost of Revenue |
$79.82 M |
$5.13 M |
$4.53 M |
$3.43 M |
$1.86 M |
$0.00 |
Gross Profit |
-$73.91 M |
-$5.13 M |
-$4.53 M |
-$3.43 M |
-$1.86 M |
$36,000.00 |
Gross Profit Ratio |
-12.52 |
0 |
0 |
0 |
0 |
1 |
Research and Development
Expenses |
$93.62 M
|
$96.72 M
|
$85.25 M
|
$58.53 M
|
$50.13 M
|
$28.15 M
|
General & Administrative
Expenses |
$50.85 M
|
$44.46 M
|
$33.85 M
|
$22.58 M
|
$12.17 M
|
$9.18 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$50.85 M
|
$44.46 M
|
$33.85 M
|
$22.58 M
|
$12.17 M
|
$9.18 M
|
Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$144.47 M |
$141.18 M |
$119.10 M |
$81.11 M |
$62.30 M |
$37.33 M |
Cost And Expenses |
$144.47 M |
$141.18 M |
$119.10 M |
$81.11 M |
$62.30 M |
$37.33 M |
Interest Income |
$11.95 M |
$4.54 M |
$187,000.00 |
$591,000.00 |
$975,000.00 |
$0.00 |
Interest Expense |
$0.00 |
$4.54 M |
$50,000.00 |
$591,000.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$5.26 M
|
$5.13 M
|
$4.53 M
|
$3.43 M
|
$1.86 M
|
$347,000.00
|
EBITDA |
-$133.30 M
|
-$136.05 M
|
-$114.57 M
|
-$77.68 M
|
-$60.44 M
|
-$36.95 M
|
EBITDA Ratio |
-22.58 |
0 |
0 |
0 |
0 |
-1026.31 |
Operating Income Ratio
|
-23.47
|
0
|
0
|
0
|
0
|
-1035.94
|
Total Other
Income/Expenses Net |
$11.95 M
|
$4.54 M
|
-$50,000.00
|
$591,000.00
|
$985,000.00
|
$1.49 M
|
Income Before Tax |
-$126.61 M |
-$136.64 M |
-$119.15 M |
-$80.52 M |
-$61.32 M |
-$35.80 M |
Income Before Tax Ratio
|
-21.45
|
0
|
0
|
0
|
0
|
-994.53
|
Income Tax Expense |
$0.00 |
-$4.54 M |
-$4.48 M |
-$4.02 M |
-$985,000.00 |
$1.49 M |
Net Income |
-$126.61 M |
-$132.10 M |
-$114.67 M |
-$76.50 M |
-$60.33 M |
-$35.80 M |
Net Income Ratio |
-21.45 |
0 |
0 |
0 |
0 |
-994.53 |
EPS |
-1.96 |
-2.27 |
-2.04 |
-2.81 |
-1.31 |
-1.82 |
EPS Diluted |
-1.96 |
-2.27 |
-2.04 |
-2.81 |
-1.31 |
-1.82 |
Weighted Average Shares
Out |
$64.48 M
|
$58.11 M
|
$56.30 M
|
$27.26 M
|
$46.21 M
|
$19.69 M
|
Weighted Average Shares
Out Diluted |
$64.48 M
|
$58.11 M
|
$56.30 M
|
$27.26 M
|
$46.21 M
|
$19.69 M
|
Link |
|
|
|
|
|
|